Member Info for jdt1990

I’ve almost written off Blyvoor happening anytime soon in my head now. The guy is a crook.
Mast has IPOd but has he really got something over the line or is that just a fanfare for what he does best? Spin off assets from a company where he has pis*ed off investors enough so he forms a new company to rope in some fresh new mugs to dilute to oblivion.
I hold in Kibo at a chunky loss and stupidly used this as a hedge looking for some profits here and value to feed up there to cover losses.
Literally the ONLY thing keeping me here is the £7m mkt cap versus projects on paper and the fact POW have a stake in Haneti. Paul seems like he knows what he’s doing - moving again with KAV today, so surely he sticks a rocket up LCs arse if the drill results are good?

Deeks' beloved gold standard PCR subject to contamination. Poor fella must be seething - you cant question it with him! Not so golden anymore....

Sisu - are you Kimi Räikkönen doing a bit of investing on the side. Completely unflappable - cool calm and collected every time.

Spot on Zoom - AIM's very own Mother Theresa is back, saving us all from the AVCT ponzi scheme.
RealityHunter - Make sure you let us all know when you get your OBE for charitable services to finance.
Tit

Reality hunter is one of three under a new guise.....

So what if its a bit late as long as what is in it is CV, CE mark and S&S close to initial evaluation. Come so far a few days aint going to hurt

Here comes the nervous brigade again!

Well they do say Wiggly - "If you can't beat them join them!" - So likely story is Mologic couldn't beat AVCT and joined them.

I'm with you there Aj......for me I would expect it before 6th to cover "around end Q1" given markets closed 2nd and 5th.

Not at all stodgy - given Mologic CE marked on 28 samples and Avct already have leading S&S on 56 samples, it’s a really good question. As radio green has said, to wait for larger CV to compete before doing this suggests confidence that S&S can be replicated at scale.
Credibility seems the obvious answer to me, especially given LFTs will contain Affimers and there’s the reputation of IP that covers so many aspects of this business to protect. Bad press for Avct LFTs or LFTs containing affimers potentially has wider implications.
As we have said before, what was a race at the start has turned more into a marathon and there’s not many runners left. So if it’s worth doing (which clearly it is now) it’s worth doing properly.

Robbo buddy- I’ll ask you three questions and suggest you go find the answers, they will show you what a crock of sh*t that article is.
1. Who wrote it?
2. Who pays for Avcts R&D
3. What % of issued share capital was the 140k options exercised? Dilution, really?

Stodgy - I think another thing to consider is the awful press LFTs have had, you only have to read some of the comments to that Han**** tweet to see what an uphill battle the govt have to change this mindset (not to mention you’ve got the likes of Deeks bashing LFTs too)
I think a larger CV sample will be a way to give additional credibility to the product in front of the masses. Rather than a cheap Chinese test validated on 50 samples and British validated using hundreds of samples (maybe more) will stand it out from the crowd and give it better credibility vs the general public.
https://mobile.twitter.com/MattHan****/status/1376240210154029058

It’s not only ODX holders that are annoying in response to Han****’s tweet.
This little gem from some chap:
“ A few sources have said that the chemical used on these tests can cause cancer.”
And a:
“Why waste money testing healthy people”
FML no wonder we’re in such a mess when this is the moronic level of the average Joe.
Uphill struggle for Matt and Co to get people to do testing when it’s all a conspiracy to them.
Guess if you dangle the carrot OG have a test you can go to the pub they’ll be testing like mad to get into spoons for a pint and brekky and 7am!

Tbh I just want to get these S&S figures + cv out of the way to shut the trolls up....can’t listen to any more of their drivel.
Then the surprises (hopefully all good!!) can roll in

Drop Ocean - Funnily enough, I am just ripping out my fridge freezer as we speak to install the Virolens machine which will facilitate my thrice a week testing! DOn;t knwo how AS didn't see this coming.
I'm nervous now, but was already nervous about being nervous with my AVCT investment. Fill or kill sell order going in right now.
Thanks for saving me!
https://www.thebrewery.co.uk/blog/virolens-evaluation-trial/

If they are linked that's either leaky leaky or someone is confident AS will deliver on his word (I am but haven't got 2m+ to be wagering on it).
Bodes well. Big week next week.
Have a good weekend ladies and gents!

Has to be a buy, price hasn't been anywhere near 248 since opening bell. They've probable been working that all day.

London stock exchange also reporting another £2.2m worth of delayed trades after that £2m that aren't showing on LSE.

Very good point radiagreen. Hadn't thought of it like that.
I guess Mologic CE marked on 28 samples in Dec so you would have to be confident of similar numbers to hold off on CE marking when you already have a 56 sample in the bag, and a good one at that!

We all know what's due - just a case of when. Going to be riddled with idiots over the next week or so (I personally think anytime before the 6th is acceptable given market hols 2nd and 5th). Going to feel like an eternity until that red dot lands so think I'll lay low. Wasted enough breath on the trolls in the last few months.
Just please AS - don't disappoint!

Well its certainly not 40% better sens than AVCT's initial evaluation......40% improvement on 96.7%, some quick maffs says that doesn't quite add up does it Trev.

So that must mean 40% better than the tests on the market i.e. cr*ppy Innova test. Otherwise, why be so vague. What a wordsmith.

Not if you aren't replacing them numbnuts.

Trevor Nicholls and Paul Fry are still active NEDs - two is plenty sufficient. Plus Eliot Forster as Non Exec Chairman.